Oxford Immunotec (OXFD) Reports Q4 Revenues Above Estimates; Offers FY19 Revenue Mid-Point Guidance Above Consensus

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/16/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. HTFL
6. SNDK
7. WDAY
8. ADYEN:NA
9. DVLT
10. ADYYF

Go back to Oxford Immunotec (OXFD) Reports Q4 Revenues Above Estimates; Offers FY19 Revenue Mid-Point Guidance Above Consensus

Oxford Immunotec Reports Fourth Quarter and Full Year 2018 Financial Results

March 11, 2019 4:10 PM EDT

OXFORD, United Kingdom and MARLBOROUGH, Mass., March 11, 2019 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq: OXFD) (the "Company"), a global, high-growth diagnostics company, today announced fourth quarter and full year 2018 financial results.

By revenue type, total revenues were, in millions:

 Three Months Ended December 31, Full Year Ended December... More